GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Formosa Pharmaceuticals Inc (TPE:6838) » Definitions » Gross-Profit-to-Asset %

Formosa Pharmaceuticals (TPE:6838) Gross-Profit-to-Asset % : -0.13% (As of Mar. 2025)


View and export this data going back to 2021. Start your Free Trial

What is Formosa Pharmaceuticals Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Formosa Pharmaceuticals's annualized Gross Profit for the quarter that ended in Mar. 2025 was NT$-2.66 Mil. Formosa Pharmaceuticals's average Total Assets over the quarter that ended in Mar. 2025 was NT$2,085.99 Mil. Therefore, Formosa Pharmaceuticals's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2025 was -0.13%.


Formosa Pharmaceuticals Gross-Profit-to-Asset % Historical Data

The historical data trend for Formosa Pharmaceuticals's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Formosa Pharmaceuticals Gross-Profit-to-Asset % Chart

Formosa Pharmaceuticals Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Gross-Profit-to-Asset %
Get a 7-Day Free Trial - 4.91 0.04 2.10 6.20

Formosa Pharmaceuticals Quarterly Data
Dec19 Dec20 Jun21 Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Gross-Profit-to-Asset % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 25.83 0.95 0.14 0.50 -0.13

Competitive Comparison of Formosa Pharmaceuticals's Gross-Profit-to-Asset %

For the Biotechnology subindustry, Formosa Pharmaceuticals's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Formosa Pharmaceuticals's Gross-Profit-to-Asset % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Formosa Pharmaceuticals's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Formosa Pharmaceuticals's Gross-Profit-to-Asset % falls into.


;
;

Formosa Pharmaceuticals Gross-Profit-to-Asset % Calculation

Formosa Pharmaceuticals's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2024 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Dec. 2024 )/( (Total Assets (A: Dec. 2023 )+Total Assets (A: Dec. 2024 ))/ count )
=118.99/( (1726.781+2112.272)/ 2 )
=118.99/1919.5265
=6.20 %

Formosa Pharmaceuticals's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2025 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Mar. 2025 )/( (Total Assets (Q: Dec. 2024 )+Total Assets (Q: Mar. 2025 ))/ count )
=-2.664/( (2112.272+2059.702)/ 2 )
=-2.664/2085.987
=-0.13 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Mar. 2025) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


Formosa Pharmaceuticals Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Formosa Pharmaceuticals's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.


Formosa Pharmaceuticals Business Description

Traded in Other Exchanges
N/A
Address
No. 57, Fuxing North Road, 8th Floor 6, Songshan District, Taipei, TWN, 105
Formosa Pharmaceuticals Inc. is a late-preclinical and early-clinical-stage biopharmaceutical company with a focus on the indications of ophthalmology, oncology, and anti-infectives.

Formosa Pharmaceuticals Headlines

No Headlines